Literature DB >> 21952248

TLR4 activation and IL-6-mediated cross talk between adipocytes and mononuclear cells synergistically stimulate MMP-1 expression.

Devadoss J Samuvel1, Junfei Jin, Kamala P Sundararaj, Yanchun Li, Xiaoming Zhang, Maria F Lopes-Virella, Yan Huang.   

Abstract

Obesity is associated with increased monocyte infiltration into adipose tissue and hence increased interaction between adipocytes and monocytes. Although it has been shown that matrix metalloproteinases (MMP) play a critical role in adipose tissue development, the effect of adipocyte and monocyte interaction on MMP production remains largely unknown. Furthermore, although it has been shown that Toll-like receptor 4 (TLR4), a receptor mediating innate immune response, plays an important role in the obesity-associated inflammation and insulin resistance, the effect of TLR4 activation in coculture of adipocytes and monocytes on MMP production has not been investigated. In this study, we cocultured adipocytes with U937 mononuclear cells in a Transwell coculture system and activated TLR4 with lipopolysaccharide or palmitic acid. We found that TLR4 activation and the coculture had a synergistic effect on MMP-1 production. In our further investigation on the underlying mechanisms, it was indicated that adipocyte-derived IL-6 and TLR4 activation acted in concert to synergistically stimulate MMP-1 expression by U937 cells. Taken together, this study has uncovered a novel mechanism potentially involved in MMP-1 up-regulation in adipose tissue, which may facilitate adipose tissue development and obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952248      PMCID: PMC3230059          DOI: 10.1210/en.2011-1026

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  36 in total

Review 1.  Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue.

Authors:  Valerie Christiaens; H Roger Lijnen
Journal:  Arch Physiol Biochem       Date:  2006 Oct-Dec       Impact factor: 4.076

2.  Comparative expression analysis of isolated human adipocytes and the human adipose cell lines LiSa-2 and PAZ6.

Authors:  E A van Beek; A H Bakker; P M Kruyt; C Vink; W H Saris; N L W Franssen-van Hal; J Keijer
Journal:  Int J Obes (Lond)       Date:  2008-02-19       Impact factor: 5.095

Review 3.  Angiogenesis and development of adipose tissue.

Authors:  V Christiaens; H R Lijnen
Journal:  Mol Cell Endocrinol       Date:  2009-08-15       Impact factor: 4.102

4.  Matrix metalloproteinase inhibition impairs adipose tissue development in mice.

Authors:  H R Lijnen; E Maquoi; L B Hansen; B Van Hoef; L Frederix; D Collen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

5.  Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes.

Authors:  Kolapo M Ajuwon; Michel E Spurlock
Journal:  J Nutr       Date:  2005-08       Impact factor: 4.798

6.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

7.  Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1.

Authors:  S P Cousin; S R Hügl; C E Wrede; H Kajio; M G Myers; C J Rhodes
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

Review 8.  Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue.

Authors:  R Cancello; K Clément
Journal:  BJOG       Date:  2006-08-10       Impact factor: 6.531

9.  Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity.

Authors:  Marciane Milanski; Giovanna Degasperi; Andressa Coope; Joseane Morari; Raphael Denis; Dennys E Cintra; Daniela M L Tsukumo; Gabriel Anhe; Maria E Amaral; Hilton K Takahashi; Rui Curi; Helena C Oliveira; José B C Carvalheira; Silvana Bordin; Mário J Saad; Lício A Velloso
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

10.  Adipose tissue mass can be regulated through the vasculature.

Authors:  Maria A Rupnick; Dipak Panigrahy; Chen-Yu Zhang; Susan M Dallabrida; Bradford B Lowell; Robert Langer; M Judah Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

View more
  5 in total

1.  Effect of Growth Hormone Treatment on the Concentration of Selected Metabolic Markers in Girls With Turner Syndrome.

Authors:  Ewa Błaszczyk; Jakub Gawlik; Joanna Gieburowska; Agnieszka Tokarska; Małgorzata Kimsa-Furdzik; Grzegorz Hibner; Tomasz Francuz; Aneta Gawlik
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

Review 2.  Innate immunity in diabetes and diabetic nephropathy.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

3.  Diffuse optical spectroscopic imaging of subcutaneous adipose tissue metabolic changes during weight loss.

Authors:  G Ganesan; R V Warren; A Leproux; M Compton; K Cutler; S Wittkopp; G Tran; T O'Sullivan; S Malik; P R Galassetti; B J Tromberg
Journal:  Int J Obes (Lond)       Date:  2016-04-22       Impact factor: 5.095

4.  Brain-Derived Neurotropic Factor, Vascular Endothelial Growth Factor and Matrix Metalloproteinases as Markers of Metabolic Status in Non-Growth Hormone-Treated Girls With Turner Syndrome.

Authors:  Ewa Błaszczyk; Jakub Gawlik; Joanna Gieburowska; Agnieszka Tokarska; Małgorzata Kimsa-Furdzik; Grzegorz Hibner; Tomasz Francuz; Aneta Monika Gawlik
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

5.  Selected Metabolic Markers in Girls with Turner Syndrome: A Pilot Study.

Authors:  E Błaszczyk; M Lorek; T Francuz; J Gieburowska; A Gawlik
Journal:  Int J Endocrinol       Date:  2018-08-29       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.